Hamburger A W, Jones S E, Salmon S E
Prog Clin Biol Res. 1980;48:43-52.
Growth of cells from patients with lymphoma was promoted by feeder layers containing medium conditioned by adherent spleen cells of mineral-oil-primed BALB/c mice or by cells from a human B lymphocyte line (RPMI 1788). Sixty-five patients with all histologic types of non-Hodgkin lymphoma were studied. Lymphoid colony growth was obtained in 61% of bone marrows and 50% of lymph nodes histologically involved by lymphocytic lymphoma. Conversely, colony growth was observed in only a single instance from 49 bone marrows without overt lymphoma and was not observed in cultures of normal lymph nodes, spleens, bone marrows, peripheral blood, or thymuses. Colonies appeared within four days of plating and reached peak size in 7--10 days. Plating efficiency ranged from 0.001% to 0.1%. Morphological, histochemical, and immunological studies of cells from the colonies identified them as lymphoid, and sufficient evidence is available to designate the colony-forming units as putative lymphoma stem cells.
来自淋巴瘤患者的细胞生长,可被含有经矿物油预处理的BALB/c小鼠贴壁脾细胞条件培养基的饲养层,或来自人B淋巴细胞系(RPMI 1788)的细胞所促进。对65例所有组织学类型的非霍奇金淋巴瘤患者进行了研究。在组织学上受淋巴细胞淋巴瘤累及的骨髓中,61%出现淋巴样集落生长;在淋巴结中,50%出现集落生长。相反,在49例无明显淋巴瘤的骨髓中,仅在1例中观察到集落生长,而在正常淋巴结、脾脏、骨髓、外周血或胸腺的培养物中未观察到集落生长。接种后4天内出现集落,并在7 - 10天达到最大尺寸。接种效率为0.001%至0.1%。对集落细胞进行的形态学、组织化学和免疫学研究表明它们为淋巴样细胞,并且有足够的证据将集落形成单位认定为假定的淋巴瘤干细胞。